Abiomed Inc (NASDAQ:ABMD)

190.54
Delayed Data
As of Sep 16
 +4.13 / +2.22%
Today’s Change
180.00
Today|||52-Week Range
459.75
-41.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues181.8M200.6M207.1M207.7M
 
 
 
 
 
Cost of Goods Sold26.5M30.4M30.9M32.7M
 
 
 
 
 
Depreciation And Amortization3.4M3.6M4.0M4.4M
 
 
 
 
 
 
Operating ExpensesGross Income151.9M166.5M172.2M170.6M
 
 
 
 
 
General Expenses101.5M103.9M107.9M109.5M
 
 
 
 
 
Research And Development22.6M23.7M26.6M23.4M
 
 
 
 
 
Total Operating Expenses131.3M138.0M142.7M146.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income50.5M62.6M64.4M61.1M
 
 
 
 
 
Extraordinary Credit0.000.0032.2M0.00
 
 
Extraordinary Charge-162.0K-252.0K---356.0K
 
 
 
 
Other Expenses-158.0K-20.0K-828.0K39.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income51.8M64.5M98.5M103.1M
 
 
 
 
 
Income Taxes-1.7M-19.6M-24.6M-14.2M
 
 
 
 
 
Net Income50.1M44.9M74.0M88.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS45.0M45.0M45.1M45.2M
 
 
 
 
 
Shares To Calculate EPS Diluted46.2M46.1M46.2M46.1M
 
 
 
 
 
 
Earnings Per ShareEPS$1.09$0.97$1.60$1.93
 
 
 
 
 
EPS Diluted$1.09$0.97$1.60$1.93